Further, investigations assessing the impact of anti-TNF agents on intermediary metabolism seemed to show that a TNF-alpha blockade may improve insulin resistance and lipid profiles, which in turn appeared to be associated with overweight and obesity. The gene discussed is TNF; the disease is Insulin resistance.